PE20090878A1 - Composicion orodispersable sin mal olor o mal sabor que comprende acidos grasos poliinsaturados - Google Patents
Composicion orodispersable sin mal olor o mal sabor que comprende acidos grasos poliinsaturadosInfo
- Publication number
- PE20090878A1 PE20090878A1 PE2008001804A PE2008001804A PE20090878A1 PE 20090878 A1 PE20090878 A1 PE 20090878A1 PE 2008001804 A PE2008001804 A PE 2008001804A PE 2008001804 A PE2008001804 A PE 2008001804A PE 20090878 A1 PE20090878 A1 PE 20090878A1
- Authority
- PE
- Peru
- Prior art keywords
- fatty acids
- bad
- composition
- dispersible
- polyinsaturated
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 235000014113 dietary fatty acids Nutrition 0.000 title abstract 2
- 239000000194 fatty acid Substances 0.000 title abstract 2
- 229930195729 fatty acid Natural products 0.000 title abstract 2
- 150000004665 fatty acids Chemical class 0.000 title abstract 2
- 239000000796 flavoring agent Substances 0.000 title 1
- 235000019634 flavors Nutrition 0.000 title 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 title 1
- 239000010931 gold Substances 0.000 title 1
- 229910052737 gold Inorganic materials 0.000 title 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 abstract 2
- SBHCLVQMTBWHCD-UHFFFAOYSA-N icosa-2,4,6,8,10-pentaenoic acid Chemical compound CCCCCCCCCC=CC=CC=CC=CC=CC(O)=O SBHCLVQMTBWHCD-UHFFFAOYSA-N 0.000 abstract 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
- 229930195725 Mannitol Natural products 0.000 abstract 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 abstract 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 abstract 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 abstract 1
- 230000003143 atherosclerotic effect Effects 0.000 abstract 1
- 239000001506 calcium phosphate Substances 0.000 abstract 1
- 229910000389 calcium phosphate Inorganic materials 0.000 abstract 1
- 235000011010 calcium phosphates Nutrition 0.000 abstract 1
- 229960000913 crospovidone Drugs 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 239000000594 mannitol Substances 0.000 abstract 1
- 235000010355 mannitol Nutrition 0.000 abstract 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 abstract 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 abstract 1
- 239000008108 microcrystalline cellulose Substances 0.000 abstract 1
- 229940016286 microcrystalline cellulose Drugs 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 229940012843 omega-3 fatty acid Drugs 0.000 abstract 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 abstract 1
- 239000006014 omega-3 oil Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 abstract 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 abstract 1
- 239000007962 solid dispersion Substances 0.000 abstract 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 1
- 239000000811 xylitol Substances 0.000 abstract 1
- 235000010447 xylitol Nutrition 0.000 abstract 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 abstract 1
- 229960002675 xylitol Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/84—Flavour masking or reducing agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE CONTIENE: A) ACIDOS GRASOS POLIINSATURADOS (PUFA) TALES COMO ACIDOS GRASOS OMEGA-3, ACIDO EICOSAPENTENOICO (EPA), ACIDO LINOLEICO, ACEITE DE PESCADO, ENTRE OTROS, EN UNA CANTIDAD DE 5% A 70% EN PESO DE LA COMPOSICION; B) UN DISGREGANTE QUE ES UNA DISPERSION SOLIDA QUE COMPRENDE CELULOSA MICROCRISTALINA, CROSPOVIDONA Y FOSFATO DE CALCIO DIBASICO DISPERSOS EN UNA MEZCLA DE MANITOL Y XILITOL; Y C) UN MINERAL Y/O VITAMINA ADICIONAL. DICHA COMPOSICION SE PRESENTA EN FORMA DE COMPRIMIDO ORODISPERSABLE CON TIEMPO DE DISGREGACION MENOR O IGUAL A 100 SEGUNDOS SIENDO UTIL EN PREVENIR O REDUCIR EL RIESGO DE ENFERMEDADES ATEROSCLEROTICAS, CARDIOVASCULARES, ALIVIAR TRASTORNOS HORMONALES
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07291305 | 2007-10-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20090878A1 true PE20090878A1 (es) | 2009-07-03 |
Family
ID=40279125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2008001804A PE20090878A1 (es) | 2007-10-30 | 2008-10-21 | Composicion orodispersable sin mal olor o mal sabor que comprende acidos grasos poliinsaturados |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20150038583A9 (es) |
| EP (1) | EP2214628B1 (es) |
| AR (1) | AR069129A1 (es) |
| AT (1) | ATE529095T1 (es) |
| AU (1) | AU2008317921B2 (es) |
| BR (1) | BRPI0818797A2 (es) |
| CA (1) | CA2703818C (es) |
| ES (1) | ES2373624T3 (es) |
| MX (1) | MX2010003843A (es) |
| PE (1) | PE20090878A1 (es) |
| PL (1) | PL2214628T3 (es) |
| RU (1) | RU2493842C2 (es) |
| TW (1) | TW200936164A (es) |
| UY (1) | UY31411A1 (es) |
| WO (1) | WO2009056248A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8784904B2 (en) | 2008-04-10 | 2014-07-22 | U.S. Nutraceuticals, LLC | Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use |
| US9770047B2 (en) | 2008-04-10 | 2017-09-26 | U.S. Nutraceuticals, LLC | Perilla seed composition |
| US8586104B2 (en) | 2008-04-10 | 2013-11-19 | U.S. Nutraceuticals, LLC | Plant derived seed extract rich in essentially fatty acids derived from Salvia hispanica L. seed: composition of matter, manufacturing process and use |
| US9610313B2 (en) | 2008-04-10 | 2017-04-04 | U.S. Nutraceuticals | Eye health composition and method using plant derived seed extract rich in essential fatty acids derived from perilla seed and carotenoids |
| US10744070B2 (en) | 2015-06-19 | 2020-08-18 | University Of Southern California | Enteral fast access tract platform system |
| WO2016205754A1 (en) | 2015-06-19 | 2016-12-22 | University Of Southern California | Compositions and methods for modified nutrient delivery |
| CN110237261A (zh) * | 2019-07-30 | 2019-09-17 | 珠海市东辰制药有限公司 | 一种复合崩解剂及其制备方法 |
| US12599544B2 (en) | 2024-05-09 | 2026-04-14 | Alsteni Medical, Inc. | Intraoral gastrointestinal access device and related methods |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3702031A1 (de) * | 1987-01-24 | 1988-08-04 | Basf Ag | Verfahren zur herstellung von mikrodispersen fischoelpraeparaten |
| JPH08259943A (ja) * | 1995-03-21 | 1996-10-08 | Nippon Suisan Kaisha Ltd | 乳化油脂用酸化安定剤 |
| US6630192B2 (en) * | 1995-04-07 | 2003-10-07 | Brandeis University | Increasing the HDL level and the HDL/LDL ratio in human serum by balancing saturated and polyunsaturated dietary fatty acids |
| JP3841804B2 (ja) * | 2003-10-15 | 2006-11-08 | 富士化学工業株式会社 | 口腔内速崩壊性錠剤用の組成物 |
| AU2006211023B2 (en) * | 2005-02-03 | 2012-05-24 | Takeda Nycomed As | Fast wet-massing method for the preparation of calcium-containing compositions |
-
2008
- 2008-10-20 UY UY31411A patent/UY31411A1/es not_active Application Discontinuation
- 2008-10-21 CA CA2703818A patent/CA2703818C/en not_active Expired - Fee Related
- 2008-10-21 BR BRPI0818797-5A2A patent/BRPI0818797A2/pt not_active Application Discontinuation
- 2008-10-21 AT AT08846097T patent/ATE529095T1/de active
- 2008-10-21 EP EP08846097A patent/EP2214628B1/en not_active Not-in-force
- 2008-10-21 AU AU2008317921A patent/AU2008317921B2/en not_active Ceased
- 2008-10-21 RU RU2010121715/15A patent/RU2493842C2/ru not_active IP Right Cessation
- 2008-10-21 ES ES08846097T patent/ES2373624T3/es active Active
- 2008-10-21 PL PL08846097T patent/PL2214628T3/pl unknown
- 2008-10-21 WO PCT/EP2008/008883 patent/WO2009056248A1/en not_active Ceased
- 2008-10-21 MX MX2010003843A patent/MX2010003843A/es active IP Right Grant
- 2008-10-21 PE PE2008001804A patent/PE20090878A1/es not_active Application Discontinuation
- 2008-10-29 TW TW097141492A patent/TW200936164A/zh unknown
- 2008-10-30 AR ARP080104762A patent/AR069129A1/es unknown
-
2010
- 2010-04-30 US US12/799,743 patent/US20150038583A9/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20150038583A9 (en) | 2015-02-05 |
| AR069129A1 (es) | 2009-12-30 |
| BRPI0818797A2 (pt) | 2014-10-07 |
| MX2010003843A (es) | 2010-07-30 |
| RU2010121715A (ru) | 2011-12-10 |
| CA2703818A1 (en) | 2009-05-07 |
| CA2703818C (en) | 2016-01-05 |
| UY31411A1 (es) | 2009-05-29 |
| AU2008317921A1 (en) | 2009-05-07 |
| ES2373624T3 (es) | 2012-02-07 |
| PL2214628T3 (pl) | 2012-03-30 |
| RU2493842C2 (ru) | 2013-09-27 |
| TW200936164A (en) | 2009-09-01 |
| ATE529095T1 (de) | 2011-11-15 |
| EP2214628B1 (en) | 2011-10-19 |
| AU2008317921B2 (en) | 2014-04-03 |
| US20100216885A1 (en) | 2010-08-26 |
| WO2009056248A1 (en) | 2009-05-07 |
| EP2214628A1 (en) | 2010-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20090878A1 (es) | Composicion orodispersable sin mal olor o mal sabor que comprende acidos grasos poliinsaturados | |
| McNamara et al. | Omega-3 fatty acid deficiency increases constitutive pro-inflammatory cytokine production in rats: relationship with central serotonin turnover | |
| UA102478C2 (en) | Capsule composition | |
| EP3713550A2 (en) | Multifunctional formulations and methods to control dermatitis and pruritus | |
| Jang et al. | Perilla oil improves blood flow through inhibition of platelet aggregation and thrombus formation | |
| Wu et al. | Alleviation of N-methyl-D-aspartate receptor-dependent long-term depression via regulation of the glycogen synthase kinase-3β pathway in the amygdala of a valproic acid-induced animal model of autism | |
| CA2880708C (en) | Plant extracts for improving cognitive health and function | |
| PE20060016A1 (es) | Solidos supersaturados estabilizados de drogas lipofilicas | |
| WO2012013331A3 (en) | Capsules of active pharmaceutical ingredients and polyunsaturated fatty acids for the treatment of prostate diseases | |
| Cicero | Nutraceuticals and dietary supplements to improve quality of life and outcomes in heart failure patients | |
| UY31410A1 (es) | Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado | |
| Kumar et al. | Omega-3 fatty acids could alleviate the risks of traumatic brain injury–a mini review | |
| Strokin et al. | Neuroprotection of rat hippocampal slices exposed to oxygen–glucose deprivation by enrichment with docosahexaenoic acid and by inhibition of hydrolysis of docosahexaenoic acid-containing phospholipids by calcium independent phospholipase A2 | |
| MA38688B1 (fr) | Composition solide pour administration orale contenant de l'acide ibandronique ou un sel pharmaceutiquement acceptable de celui-ci et de la vitamine d | |
| CL2019000607A1 (es) | Composición para aplicación tópica con actividad antifúngica. | |
| WO2011060944A3 (en) | Active pharmaceutical ingredient capsules and polyunsaturated fatty acid esters | |
| Tang et al. | An Ω-3 fatty acid-deficient diet during gestation induces depressive-like behavior in rats: the role of the hypothalamo–pituitary–adrenal (HPA) system | |
| JP6663993B2 (ja) | 安定性が向上し、取り込みが改善されたホノキオール及びマグノロール製剤、並びにそれらの使用方法 | |
| Wang et al. | Antarctic krill oil exhibited synergistic effects with nobiletin and theanine in ameliorating memory and cognitive deficiency in SAMP8 mice: Applying the perspective of the sea–land combination to retard brain aging | |
| CO6341531A2 (es) | Producto alimenticio de acidos grasos con base de chia, rico en omega-3, con buena estabilidad | |
| ATE443515T1 (de) | Omega-3-fettsäuren und omega-6-fettsäuren enthaltende zusammensetzung | |
| CN1927050B (zh) | Dha微胶囊食品添加剂、dha软胶囊保健品及其应用 | |
| US20190321320A1 (en) | Prevention of psychotic disorders and/or treatment of psychotic symptoms | |
| Raghavendra et al. | Eugenol and n-3 rich garden cress seed oil as modulators of platelet aggregation and eicosanoids in Wistar albino rats | |
| ITFI20090189A1 (it) | Estratto di rhodiola per l'uso nel trattamento farmacologico di binge eating disorder e bulimia nervosa. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |